INHIBITEX, INC. (INHX) [Rocket]

In millions, except per share items	Dec-31-10	Dec-31-09	Dec-31-08	Dec-31-07	Dec-31-06	Dec-31-05	Dec-31-04	Dec-31-03
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Net income	-22.7	-17.6	-13.2	-41.5	-31.1	0.0	0.0	0.0
Depreciation and amortization	0.6	0.8	0.8	1.0	4.9	1.4	0.8	0.8
Stock-based compensation	0.9	0.5	1.5	2.0	2.6	0.5	0.5	0.2
Change in working capital [+]	1.3	0.0	-5.2	0.3	1.6	1.9	1.7	-0.8
Accounts receivable	-0.1	0.0	-0.1	0.3	-0.3	0.3	0.0	-0.3
Other current assets				0.0
Accounts payable				0.9
Accrued expenses				-1.0	2.1	1.7	1.9	-0.3
Deferred revenues				0.1	-0.2	-0.1	-0.2	-0.2
Other	1.4	-0.1	-5.1
Other operating activities	1.4	0.2	-0.4	29.9	-1.8	-38.7	-24.5	-21.7
Cash from operations	-18.4	-16.1	-16.4	-8.2	-23.8	-35.0	-21.5	-21.6

Capital expenditures	-0.1	-0.1	-0.5	-0.1	-0.2	-4.5	-1.6	-0.2
Purchases of property and equipment	-0.1	-0.1	-0.5	-0.1	-0.2	-4.5	-1.6	-0.2
Purchases of short-term investments, net	15.2	-5.2	15.1	7.0	11.8	-38.0	-14.3	-0.5
Purchases of short-term investments	-20.9	-34.4	-45.9	-75.2	-62.9	-104.2	-30.9	-15.6
Sales of short-term investments	36.1	29.2	61.0	82.2	74.7	66.2	16.6	15.0
Other cash from investing	0.0	0.0	-0.1	-3.0
Cash from investing	15.1	-5.2	14.5	4.0	11.6	-42.6	-15.9	-0.7

Issuance of common stock, net	0.9	0.0	-0.1	0.0	0.2	39.0	81.9	0.0
Other cash from financing	-0.3	21.1	-0.7			0.8	0.4	20.3
Cash from financing	0.6	21.2	-0.8	-1.3	-2.0	39.8	82.3	20.3

Free cash flow	-18.5	-16.2	-16.9	-8.2	-24.0	-39.5	-23.1	-21.7
Per share (diluted)	($0.30)	($0.35)	($0.39)	($0.24)	($0.79)	($1,463.64)	($2,021.49)	($41,295.86)

Cash paid for interest				0.1	0.3	0.2	0.2	0.2